Editors Tewari, Whelan, and Graham offer this comprehensive volume on prostate cancer diagnosis and treatment. Epidemiology and screening are discussed, followed by histopathology, biomarkers, and imaging aspects of diagnosis. Discussion of management begins with how to counsel the newly diagnosed patient and active surveillance for low-risk cases. Surgery, radiation therapy, and some novel therapies for localized cancer are presented, as well as follow-up, first intervention, and monitoring of PSA. The end of the book moves into treatment of metastatic cases, new therapies for hormone relapsed disease, and the issues of end-of-life care in untreatable cases and perspective on prostate cancer as a chronic disease. A final chapter looks at the evolving toolkit and new frontiers in research. Annotation ©2014 Ringgold, Inc., Portland, OR (protoview.com)
Do you manage patients with prostate cancer?
Could you use an expert guide examining all possible management options?
Prostate Cancer: diagnosis and clinical management providesurologists and oncologists of all levels with up-to-date, evidence-based guidance to the diagnosis, treatment and clinical management of a disease which accounts for a quarter of all cancers affecting men.
Designed to be as practical and accessible as possible, leading experts discuss key issues in prostate cancer management and examine how to deliver best practice in the clinical care of their patients. Topics covered include:
- What must be considered when counseling newly-diagnosed cancer patients
- Radical surgery options for prostate cancer
- Novel therapies for localized prostate cancer
- How should metastatic prostate cancer be diagnostic and managed
- What are the best methods of administering end of life care for the patient
Brought to you by a highly experienced editor team, and containing key points, management algorithms, practice tips and the latest AUA and EAU clinical guidelines, this is the ideal consultation tool for doctors both on the wards and in the office.
Contributors |
|
vii | |
Preface |
|
x | |
|
1 Prostate Cancer Epidemiology |
|
|
1 | (15) |
|
|
|
|
2 Diagnosis and Screening |
|
|
16 | (18) |
|
|
|
|
3 Understanding the Histopathology |
|
|
34 | (15) |
|
|
4 Markers in Prostate Cancer |
|
|
49 | (23) |
|
|
|
72 | (44) |
|
|
6 Counseling the Patient with Newly Diagnosed Prostate Cancer, Stage by Stage |
|
|
116 | (20) |
|
|
|
7 Active Surveillance in the Management of Low-Risk Prostate Cancer |
|
|
136 | (9) |
|
|
|
145 | (25) |
|
|
|
9 Radiation Therapy in the Management of Prostate Cancer |
|
|
170 | (21) |
|
|
|
10 Novel Therapies for Localized Prostate Cancer |
|
|
191 | (20) |
|
|
|
|
|
11 Posttherapy Follow-up and First Intervention |
|
|
211 | (19) |
|
|
|
|
Jean J.M.C.H. de la Rosette |
|
|
|
12 Managing Rising PSA in Naive and Posttherapy Patients |
|
|
230 | (15) |
|
|
|
13 Diagnosis and Management of Metastatic Prostate Cancer |
|
|
245 | (20) |
|
|
|
14 New Therapies in Hormone Relapsed Disease |
|
|
265 | (22) |
|
|
|
|
|
15 End of Life Care in Prostate Cancer |
|
|
287 | (11) |
|
|
16 The Long Perspective: Prostate Cancer as a Chronic Disease |
|
|
298 | (15) |
|
|
17 The Future: What's in the Toolkit for Prostate Cancer Diagnosis and Treatment? |
|
|
313 | (18) |
|
Index |
|
331 | |
Ashutosh K. Tewari, M.D., M. Ch. Ronald P. Lynch Professor of Urologic- Oncology; Director, Center for Prostate Cancer, Weill Cornell Medical College and New York Presbyterian Hospital, New York, USA
Peter Whelan, MS,FRCS, Emeritus Consultant Urological Surgeon, St. Jamess University Hospital, Leeds, and Community NHS Urologist, Leeds, UK
John D. Graham, FRCP, FRCR, Consultant in Clinical Oncology, Beacon Centre, Musgrove Park Hospital, Taunton, Somerset, UK